Edition:
India

Fujifilm Holdings Corp (4901.T)

4901.T on Tokyo Stock Exchange

4,205JPY
9:40am IST
Change (% chg)

¥-79 (-1.84%)
Prev Close
¥4,284
Open
¥4,247
Day's High
¥4,249
Day's Low
¥4,201
Volume
415,400
Avg. Vol
1,549,821
52-wk High
¥4,838
52-wk Low
¥3,934

Latest Key Developments (Source: Significant Developments)

Fujifilm sues Xerox for well over $1 bln, plus punitive damages
Monday, 18 Jun 2018 

June 18 (Reuters) - Fujifilm says its shareholders are entitled to the benefits of the transaction that xerox had agreed to:.  Full Article

Fujifilm Says Disputes Xerox's Unilateral Decision To Terminate Deal
Monday, 14 May 2018 

May 14 (Reuters) - Fujifilm Holdings Corp <4901.T>::DISPUTES XEROX'S UNILATERAL DECISION TO TERMINATE THE TRANSACTION.DOESN'T THINK XEROX HAS LEGAL RIGHT TO TERMINATE AGREEMENT, LOOKING AT ALL OPTIONS INCLUDING BRINGING LEGAL ACTION SEEKING DAMAGES.TO URGE XEROX BOARD OF DIRECTORS TO RECONSIDER THEIR DECISION.  Full Article

Taisho Pharmaceutical Holdings to sell stake in TOYAMA CHEMICAL and buy stake in Taisho Toyama Pharmaceutical
Monday, 14 May 2018 

May 14 (Reuters) - Taisho Pharmaceutical Holdings Co Ltd <4581.T>:Says it will sell entire stake in TOYAMA CHEMICAL CO., LTD. to FUJIFILM Holdings Corp <<<4901.T>>>.Says it will acquire entire stake in Taisho Toyama Pharmaceutical Co., Ltd. from TOYAMA CHEMICAL CO., LTD. .Effective July 31 .  Full Article

Fujifilm Says Has Not Received A New Proposal From Xerox
Thursday, 10 May 2018 

May 10 (Reuters) - Fujifilm Holdings Corp <4901.T>::FUJIFILM SAYS HAS NOT RECEIVED A NEW PROPOSAL FROM XEROX.FUJIFILM SAYS IF WE RECEIVE A NEW PROPOSAL, WE WILL NEED TO STUDY WHETHER IT OFFERS VALUE TO SHAREHOLDERS OF FUJIFILM.  Full Article

Xerox Reports Q1 EPS $0.08 From Continuing Operations
Thursday, 3 May 2018 

May 2 (Reuters) - Xerox Corp ::XEROX REPORTS FIRST-QUARTER 2018 RESULTS.Q1 REVENUE $2.435 BILLION VERSUS I/B/E/S VIEW $2.41 BILLION.Q1 GAAP EARNINGS PER SHARE $0.08 FROM CONTINUING OPERATIONS.Q1 ADJUSTED EARNINGS PER SHARE $0.68.Q1 EARNINGS PER SHARE VIEW $0.73 -- THOMSON REUTERS I/B/E/S.NOT PROVIDING 2018 GUIDANCE DUE TO PENDING DIRECTOR APPOINTMENT, NOMINATION, SETTLEMENT AGREEMENT WITH CARL ICAHN,DARWIN DEASON, AMONG OTHERS.XEROX-"IN NORMAL COURSE OF BUSINESS, ABSENT RECENT EVENTS,WOULD HAVE REAFFIRMED FY GUIDANCE ON REVENUE, ADJUSTED OPERATING MARGIN, CASH FLOW, ADJUSTED EPS".  Full Article

Fujifilm Shares Fall More Than 3 Percent
Wednesday, 2 May 2018 

May 2 (Reuters) - Fujifilm Holdings Corp <4901.T>::FUJIFILM SHARES FALL MORE THAN 3 PERCENT.  Full Article

Xerox Confirmed Talks With Fujifilm For Potential Increase In Consideration To Be Received By Xerox Shareholders In Proposed Deal
Friday, 27 Apr 2018 

April 27 (Reuters) - Fujifilm Holdings Corp <4901.T>::XEROX - CONFIRMED TALKS WITH FUJIFILM FOR POTENTIAL INCREASE IN CONSIDERATION TO BE RECEIVED BY XEROX SHAREHOLDERS IN PROPOSED DEAL WITH FUJI XEROX.  Full Article

Icahn & Deason Provide Four-Part Plan To Increase Xerox Shareholder Value
Wednesday, 18 Apr 2018 

April 17 (Reuters) - Carl Icahn And Darwin Deason::CARL ICAHN AND DARWIN DEASON RELEASE OPEN LETTER AND PRESENTATION TO XEROX SHAREHOLDERS.ICAHN & DEASON - PROVIDE FOUR-PART PLAN TO INCREASE XEROX SHAREHOLDER VALUE.CARL ICAHN & DARWIN DEASON SAY FOUR-PART PLAN FOR XEROX INCLUDES PROPOSAL TO RE-EVALUATE ASIA-PACIFIC MARKET WITH A "STRONGER MANAGEMENT TEAM".ICAHN & DEASON - FOUR-PART PLAN FOR XEROX INCLUDES PROPOSAL TO DRIVE BOTTOM-LINE COST SAVINGS THROUGH NETWORK CONSOLIDATION AND CHANNEL OPTIMIZATION.CARL ICAHN & DARWIN DEASON SAY FOUR-PART PLAN FOR XEROX INCLUDES PROPOSAL TO MONETIZE "UNTAPPED INTELLECTUAL PROPERTY".ICAHN AND DEASON SAYS FOUR-PART PLAN FOR XEROX INCLUDES PROPOSAL TO "UNLOCK GROWTH THROUGH NEW ADJACENT SERVICES AND PARTNERSHIPS".ICAHN & DEASON - "BELIEVE OUR PLAN COULD CREATE TOTAL VALUE OF $54 TO $64 PER SHARE" COMPARED TO ABOUT $28 PER SHARE IN THE PROPOSED FUJI TRANSACTION.CARL ICAHN & DARWIN DEASON SAY XEROX CAN DRIVE COST SAVINGS BY OPTIMIZING ITS WHOLLY-OWNED SUBSIDIARY, GLOBAL IMAGING SYSTEMS.CARL ICAHN & DARWIN DEASON SAY XEROX CAN ADD ANOTHER "POTENTIALLY SIGNIFICANT" REVENUE STREAM BY MONETIZING ITS PALO ALTO RESEARCH CENTER.  Full Article

Mylan, Biocon Seek To Accelerate Introduction Of Adalimumab Biosimilar In EU
Wednesday, 11 Apr 2018 

April 11 (Reuters) - Biocon Ltd ::MYLAN, BIOCON SEEK TO ACCELERATE INTRODUCTION OF ADALIMUMAB BIOSIMILAR IN EU.  Full Article

Mylan Partners With Fujifilm Kyowa Kirin Biologics
Wednesday, 11 Apr 2018 

April 11 (Reuters) - Mylan NV ::MYLAN PARTNERS WITH FUJIFILM KYOWA KIRIN BIOLOGICS TO COMMERCIALIZE BIOSIMILAR TO HUMIRA® (ADALIMUMAB).MYLAN NV - COMPANIES EXPECT TO RECEIVE A DECISION FROM EMA IN SECOND HALF OF 2018.MYLAN NV - FUJIFILM KYOWA KIRIN BIOLOGICS GRANTS MYLAN AN EXCLUSIVE LICENSE TO COMMERCIALIZE ADALIMUMAB BIOSIMILAR IN EUROPE.MYLAN NV - FUJIFILM KYOWA KIRIN BIOLOGICS IS ELIGIBLE TO RECEIVE A SUBSEQUENT COMMERCIALIZATION MILESTONE PAYMENT AND SALES ROYALTIES.MYLAN NV - FUJIFILM KYOWA KIRIN BIOLOGICS WILL RECEIVE AN UP-FRONT FEE UNDER DEAL.MYLAN NV -CO, FUJIFILM KYOWA KIRIN BIOLOGICS CONTINUE TO NEGOTIATE FOR COMMERCIALIZING PRODUCT IN ADDITIONAL TERRITORIES.MYLAN NV - UNDER AGREEMENT TERMS CO TO BE RESPONSIBLE FOR SALES ACTIVITY OF PRODUCT IN EUROPEAN COUNTRIES.MYLAN NV - CO, FUJIFILM KYOWA KIRIN BIOLOGICS EXPECT TO RECEIVE DECISION FROM EMA REGARDING MAA FOR PROPOSED BIOSIMILAR TO HUMIRA IN H2 2018.  Full Article

Fujifilm accuses Icahn, Deason of SEC disclosure violations, Icahn calls claim ‘easily disproven’

Fujifilm filed a $1 billion complaint in Manhattan federal court Monday, accusing Xerox of breaching a $6.1 billion agreement that would have given the Japanese company control of its longtime joint venture partner. Fujifilm claims that when the Xerox board voted to terminate the transaction on May 13, it surrendered “to the whims of activist investors Carl Icahn and Darwin Deason,” who own a combined 15 percent of Xerox’s shares and now control the Xerox board. The Japanese company